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143 Volatile organic compound analysis in the early detection of
Pseudomonas aeruginosa in cystic ﬁbrosis
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Background: Infection with Pseudomonas aeruginosa (PA) is a major cause of
morbidity and mortality in patients with cystic ﬁbrosis (CF). We have investigated
emission of volatile organic compounds (VOCs) from sputum, saliva and bacterial
cultures in order to identify VOCs associated with PA.
Methods: Fifteen samples of sputum and saliva from stable patients with CF
were studied; 11 had PA. Sputum and saliva samples, 0.2−1ml, were decanted
in to septum topped headspace vials and analysed on the day of collection. VOC
content was measured using solid phase micro-extraction ﬁbres (SPME) and gas
chromatography mass spectrometry (GCMS), following incubation for 30 mins at
60ºC and SPME headspace extraction for 20 mins. Sputum samples were also
cultured on blood agar for 3 days. Following incubation, samples were allowed to
equilibrate at 22ºC for 1 hr prior to headspace SPME extraction for 1 hr. VOCs
were assigned an identiﬁcation using Perkin Elmer Turbomass proprietary software
and NIST 2005 mass spectral database.
Results: VOCs from sputum of patients with PA were similar to those of patients
without, except for 2-Butanone which was present in 9/11 PA patients and 1/4 pa-
tients without PA. VOCs emitted from culture and saliva samples were similar,
irrespective of the presence of PA.
Discussion: The point of care recognition of PA in the sputum of patients with CF
has the potential to inﬂuence clinical care. Our initial results suggest that 2-butanone
would yield a sensitivity of 82% and a speciﬁcity of 75% for PA. This marker may
be identiﬁable from fresh samples using a sensor device. This small study needs
further work.
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Introduction: Colonization of the airways of CF patients with Pseudomonas aerug-
inosa results in faster decline of the lung function and decreased life expectancy.
Detection of infection with this pathogen as early as possible enables to start the
eradication treatment as soon as possible.
Aim: To compare the sensitivity of six PCR formats for a dilution series of
P. aeruginosa in sputum.
Materials and Methods: Sputa from CF patients positive for P. aeruginosa were
liqueﬁed by adding v/v Sputasol and were 1/5 serially diluted in a pool of liqueﬁed
sputa from CF patients negative for P. aeruginosa.
DNA was extracted with the bioMe´rieux easyMAG Nuclisens extractor. Conven-
tional PCR was performed using the Veriti 96-Well Thermal Cycler, with oprL as
the target, followed by capillary resp. agarose gel electrophoresis. Different real-
time PCR formats on the LightCycler 1.5, i.e. SYBR Green I, HybProbes and
Taqman probe, were compared with the TaqMan® P. aeruginosa detection kit on
the ABI7000.
Results: For conventional PCR, P. aeruginosa could be detected up to dilution 6
using agarose gel electrophoresis and up to dilution 7 with capillary electrophoresis.
For real-time PCR, P. aeruginosa could be detected with SYBR Green I up to
dilution 7 and up to dilution 8, i.e. up to 20−40 cfu/ml, with the HybProbes, TaqMan
probe and the TaqMan® P. aeruginosa detection kit.
Conclusion: Real-time PCR, using the HybProbes, the TaqMan probe or the
TaqMan® P. aeruginosa detection kit is 5−25 fold more sensitive for the detection
of P. aeruginosa than conventional PCR and real-time PCR using SYBR Green I.
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Background: Early detection of PA, the most threatening pathogen in CF patients,
is crucial. To date, there is no agreement about the usefulness of PCR in routine
probably due to the lack of cohort studies.
Objective: To establish an optimised protocol for the accurate molecular detection
of PA directly from CF sputum.
Methods: The reliability of four widely used DNA targets (oprL, oprI, ecf X
and rrl) was evaluated: 1) On a set of 30 PA isolates, and on 14 different
Pseudomonaceae strains (except PA) commonly found in CF patients 2) On 154
sputum samples from 95 CF patients.
Results: The oprL PCR showed the best speciﬁcity (100%) and sensitivity (100%).
RT-PCR produced a linear quantitative detection range of 8 logs (r = 0.99857), with
a lower detection limit of 10 colony-forming units (CFU)/mL (Ct=38.6±1.33). The
standardized Ct and ﬂuorescence of the DICO Extra r-gene detected inhibitors for
18.5% of clinical samples.
Discussion: It is the ﬁrst time that DICO Extra r-gene has been used as an internal
control for the PA molecular detection in CF sputum. This universal control prevents
defaults in extraction process and provides accurate detection of inhibitors. With a
lower detection limit of 10 CFU/mL as opposed to 100 CFU/mL which is usually
found with culture, this study encourages the use of molecular screening for PA in
CF patients.
Prospects: The development of this original protocol was the prerequisite of a
multicenter prospective study, which began in September 2008 and is running for
3 years in 3 centres (CRCM Roscoff, CRCM Nantes, and CHU Brest) specialized
in the management of CF patients (n = 310).
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Chronic sinusitis is a common complication in CF patients. It has been shown that
patients who have had a lung transplant are recolonised in their lung grafts with
the same clones as those that were cultured from their old lungs. We therefore
hypothesised that the sinuses may serve as a place for bacterial adaptation and
focus for lung infections.
We treated 47 CF patients (median age 16 years, range 6−50) for chronic sinusitis
with Functional Endoscopic Sinus Surgery (FESS). We evaluated whether their
sinuses serve as bacterial reservoir. Nineteen patients were chronically infected (14
with PA, 2 with Burkholderia, 2 with Achromobacter, 1 with Moraxella) and 28
were intermittently colonised (17 with PA and 11 with other CF pathogens) in their
lungs.
In chronically infected patients there was complete agreement between lung and
sinus bacteriology and genotypes. In children intermittently colonised with PA there
was agreement in 15/17 (88%) cases. After FESS 5/17 (30%) of these children are
still free from PA in their lungs (median 219 days, range 42–431). PA were organised
in bioﬁlm structures similar to those seen in sputum. In contrast to bioﬁlms from
the lungs, we found that bioﬁlms from the sinuses were only surrounded by few
inﬂammatory cells. The sinus colonisation therefore seems immunologically silent.
In intermittently colonised patients PA are most often cultured from throat ﬂora
and not from lower respiratory secretions and anti-PA antibodies are not increased.
That is why we think that the paranasal sinuses are the focus for PA infection and
that the lungs are infected by aspiration.
